Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · June 29, 2022

Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant

Journal of Clinical Oncology

 

Additional Info

Journal of Clinical Oncology
Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up
J. Clin. Oncol 2022 Jun 03;[EPub Ahead of Print], DCF Klatte, B Boekestijn, MNJM Wasser, S Feshtali Shahbazi, IS Ibrahim, JSD Mieog, SAC Luelmo, H Morreau, TP Potjer, A Inderson, JJ Boonstra, FW Dekker, HFA Vasen, JE van Hooft, BA Bonsing, ME van Leerdam

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading